DD202544A5 - Verfahren zur herstellung von pirbuterol und analoga - Google Patents

Verfahren zur herstellung von pirbuterol und analoga Download PDF

Info

Publication number
DD202544A5
DD202544A5 DD82237264A DD23726482A DD202544A5 DD 202544 A5 DD202544 A5 DD 202544A5 DD 82237264 A DD82237264 A DD 82237264A DD 23726482 A DD23726482 A DD 23726482A DD 202544 A5 DD202544 A5 DD 202544A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
tert
pyridine
hydroxy
hydrogen
Prior art date
Application number
DD82237264A
Other languages
German (de)
English (en)
Inventor
Berkeley W Cue
Stephen S Massett
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD202544A5 publication Critical patent/DD202544A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Catalysts (AREA)
DD82237264A 1981-02-09 1982-02-08 Verfahren zur herstellung von pirbuterol und analoga DD202544A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23292381A 1981-02-09 1981-02-09

Publications (1)

Publication Number Publication Date
DD202544A5 true DD202544A5 (de) 1983-09-21

Family

ID=22875140

Family Applications (2)

Application Number Title Priority Date Filing Date
DD82237264A DD202544A5 (de) 1981-02-09 1982-02-08 Verfahren zur herstellung von pirbuterol und analoga
DD82253605A DD210034A5 (de) 1981-02-09 1982-02-08 Verfahren zur herstellung von pirbuterol

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD82253605A DD210034A5 (de) 1981-02-09 1982-02-08 Verfahren zur herstellung von pirbuterol

Country Status (26)

Country Link
EP (4) EP0058071B1 (ja)
JP (4) JPS57150665A (ja)
KR (1) KR860000623B1 (ja)
AR (4) AR231439A1 (ja)
AT (2) ATE20882T1 (ja)
AU (1) AU530826B2 (ja)
CA (1) CA1179677A (ja)
CS (1) CS229678B2 (ja)
DD (2) DD202544A5 (ja)
DE (2) DE3272793D1 (ja)
DK (1) DK157541C (ja)
EG (1) EG16242A (ja)
ES (4) ES8305721A1 (ja)
FI (1) FI820396L (ja)
GR (1) GR75867B (ja)
GT (1) GT198273686A (ja)
IE (2) IE52326B1 (ja)
IL (1) IL64954A (ja)
NO (4) NO820371L (ja)
NZ (1) NZ199646A (ja)
PH (4) PH20622A (ja)
PL (4) PL130678B1 (ja)
PT (1) PT74397B (ja)
SU (4) SU1194273A3 (ja)
YU (3) YU42756B (ja)
ZA (1) ZA82778B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3615293A1 (de) * 1986-05-06 1987-11-12 Bayer Ag Verwendung von heteroarylethylaminen zur leistungsfoerderung bei tieren, heteroarylethylamine und verfahren zu ihrer herstellung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700681A (en) * 1971-02-16 1972-10-24 Pfizer 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines
BE795937A (fr) * 1972-03-01 1973-08-27 Pepro Procede d'hydroxymethylation d'une 3-hydroxy-pyridine substituee
AR207639A1 (es) * 1973-12-26 1976-10-22 Pfizer Un procedimiento para preparar pirido (3,2-d)1,3-dioxin-6-epoxietanos y compuestos intermediarios desprovistos de actividad terapeutica
US4031108A (en) * 1974-10-09 1977-06-21 Pfizer Inc. 2-Hydroxymethyl-3-benzyloxypyridine-6-epoxyethane
US3952101A (en) * 1975-04-14 1976-04-20 Smithkline Corporation α-Amino methyl-5-hydroxy-2-pyridinemethanols

Also Published As

Publication number Publication date
NO824275L (no) 1982-08-10
IE820273L (en) 1982-08-09
JPS57150665A (en) 1982-09-17
KR830009028A (ko) 1983-12-17
IE52326B1 (en) 1987-09-16
NO824273L (no) 1982-08-10
AU8027182A (en) 1982-08-19
EP0058069A2 (en) 1982-08-18
JPS6193164A (ja) 1986-05-12
DE3272061D1 (en) 1986-08-28
GR75867B (ja) 1984-08-02
YU42908B (en) 1988-12-31
YU43389B (en) 1989-06-30
JPS60208962A (ja) 1985-10-21
EP0058072A3 (en) 1982-08-25
SU1217253A3 (ru) 1986-03-07
PL235000A1 (en) 1983-04-11
EP0058070A3 (en) 1982-08-25
PH19167A (en) 1986-01-16
PT74397B (en) 1984-10-09
YU201984A (en) 1985-04-30
SU1250170A3 (ru) 1986-08-07
EP0058071A3 (en) 1982-08-25
CS229678B2 (en) 1984-06-18
NO824274L (no) 1982-08-10
AR229712A1 (es) 1983-10-31
JPS6135184B2 (ja) 1986-08-12
PL239427A1 (en) 1983-04-25
AR229373A1 (es) 1983-07-29
ES518971A0 (es) 1984-03-01
GT198273686A (es) 1983-07-30
IL64954A (en) 1986-03-31
ES8403111A1 (es) 1984-03-01
PL130678B1 (en) 1984-08-31
IE820275L (en) 1982-08-09
DE3272793D1 (en) 1986-10-02
FI820396L (fi) 1982-08-10
DK157541B (da) 1990-01-22
ES8403110A1 (es) 1984-03-01
YU42756B (en) 1988-12-31
NO820371L (no) 1982-08-10
JPS60208964A (ja) 1985-10-21
YU201884A (en) 1985-04-30
ATE20882T1 (de) 1986-08-15
ES509430A0 (es) 1983-04-16
EP0058069A3 (en) 1982-09-01
EP0058070A2 (en) 1982-08-18
DK157541C (da) 1990-06-11
AU530826B2 (en) 1983-07-28
EP0058072A2 (en) 1982-08-18
CA1179677A (en) 1984-12-18
EP0058069B1 (en) 1986-08-27
ES8403112A1 (es) 1984-03-01
JPS6059911B2 (ja) 1985-12-27
SU1194273A3 (ru) 1985-11-23
ES518972A0 (es) 1984-03-01
ZA82778B (en) 1983-01-26
KR860000623B1 (ko) 1986-05-24
PL130918B1 (en) 1984-09-29
PH19164A (en) 1986-01-16
DD210034A5 (de) 1984-05-30
PT74397A (en) 1982-03-01
ES518973A0 (es) 1984-03-01
AR231439A1 (es) 1984-11-30
PL130580B1 (en) 1984-08-31
PH20292A (en) 1986-11-18
SU1240354A3 (ru) 1986-06-23
EP0058071B1 (en) 1986-07-23
YU26682A (en) 1985-04-30
PH20622A (en) 1987-03-06
EP0058071A2 (en) 1982-08-18
IL64954A0 (en) 1982-04-30
PL239428A1 (en) 1983-04-25
PL239426A1 (en) 1983-04-25
JPS6119624B2 (ja) 1986-05-17
AR229374A1 (es) 1983-07-29
PL130917B1 (en) 1984-09-29
ATE21691T1 (de) 1986-09-15
ES8305721A1 (es) 1983-04-16
DK52182A (da) 1982-09-17
EG16242A (en) 1989-01-30
JPS6059231B2 (ja) 1985-12-24
IE52325B1 (en) 1987-09-16
NZ199646A (en) 1985-11-08

Similar Documents

Publication Publication Date Title
DE60004087T2 (de) Verfahren und zwischenprodukte zur herstellung von imidazolinon alpha v integrin antagonisten
EP0606065B1 (de) Verfahren zur Herstellung von Biphenylderivaten
EP1049674B1 (de) Verfahren zur herstellung von (-)cis-3- hydroxy-1- methyl-4-(2, 4,6-trimethoxyphenyl)- piperidin
DE68922936T2 (de) Verfahren zur Herstellung von Serinol.
EP1607090B1 (de) Asimadolin für die Behandlung des Irritable Bowel Syndroms
DE2750553C2 (de) Verfahren zur Herstellung von gamma-Pyronen
DD202544A5 (de) Verfahren zur herstellung von pirbuterol und analoga
CH619700A5 (ja)
US4031108A (en) 2-Hydroxymethyl-3-benzyloxypyridine-6-epoxyethane
DE2609015A1 (de) Verfahren zur herstellung von benz (f)-2,5-oxazocinen
DE69016647T2 (de) Verfahren zur herstellung von alpha-beta-ungesättigten ketonen.
DE2452536A1 (de) Pyrrolidone und verfahren zu ihrer herstellung
DE69126326T2 (de) Verfahren und Zwischenprodukte zur Herstellung von anxiolytisch wirksamen Perhydro-1H-pyrido[1,2-a]pyrazinen
DE69200717T2 (de) Verfahren zur Herstellung von N,N-Dihydrocarbylhydroxylaminen.
EP0177448B1 (de) Verfahren zur Herstellung von 1,2-Benzoxathiin-Derivaten
DE2034682A1 (de) Herstellung von eis 1 Propenylphos phonsaure
DE2461307B2 (de) 2-Hydroxymethyl-3-hydroxypyridin-6-epoxyäthan-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von 2-Hydroxymethyl-3hydroxy-6-(l -hydroxy-2-tert.butylaminoäthyOpyridin
EP0171046B1 (de) Verfahren zur Herstellung von Pantolacton
EP0423595B1 (de) Verfahren zur Herstellung von 3-Trichlormethyl-pyridin
EP0087654B1 (de) Verfahren zur Herstellung von 1-(4-Chlorbenzoyl)-5-methoxy-2-methyl-3-indolacetoxyessigsäure
JP3382681B2 (ja) 含フッ素化合物およびその製法
DE19533219A1 (de) Verfahren zur Herstellung von N-Alkenylcarbaminsäureestern
EP1392652B1 (de) Verfahren zur herstellung von 1,3-disubstituierten 2-nitroguanidinen
EP0354301A2 (de) Verfahren zur Herstellung von Chinuclidin-3-methanol
AT359210B (de) Verfahren zur herstellung von desoxyvincamin- amiden

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee